Institutional investors hold a majority ownership of CTLT through the 98.96% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended March 2019, these large investors purchased a net $3.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORRIS, PERNE & FRENCH LLP Bought 136.0 Thousand shares of Catalent Inc
COMERICA BANK (INVESTMENT MANAGE... Bought 74.9 Thousand shares of Catalent Inc
HUNTER PERKINS CAPITAL MANAGEMEN... Bought 69.8 Thousand shares of Catalent Inc